|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Maryland |
| Information provided by: | University of Maryland |
| ClinicalTrials.gov Identifier: | NCT00654264 |
Purpose
This is an unblinded pilot study comparing (against a randomized control day without water immersion) the diuretic and natriuretic effects of water immersion in patients with right heart failure.
| Condition | Intervention | Phase |
|
Right Sided Cardiac Failure |
Procedure: Water immersion |
Phase IV |
| MedlinePlus related topics: | Drinking Water Heart Failure |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study |
| Official Title: | Water Immersion in Right-Sided Heart Failure: A Pilot Study |
| Estimated Enrollment: | 13 |
| Study Start Date: | December 2007 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|
1
Patients will have water immersion on first day and sitting in a tub without water on the second day.
|
Procedure: Water immersion
Subjects will sit in tub for four hours.
|
|
2
Patients will sit in a tub without water on the first day and have water immersion on the second day.
|
Procedure: Water immersion
Subjects will sit in tub for four hours.
|
Patients will be immersed in a tub for 3 hours (on one day) and neurohormones will be obtained before and after immersion. Urine will be collected for quantification and evaluation of sodium concentration.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Stephen Gottlieb, MD | 4103288788 | sgottlie@medicine.umaryland.edu |
| United States, Maryland | |||||
| University of Maryland | Recruiting | ||||
| Baltimore, Maryland, United States, 21201 | |||||
| Contact: Stephen Gottlieb, MD 410-328-8788 | |||||
| University of Maryland |
| Principal Investigator: | Stephen Gottlieb, MD | University of Maryland |
More Information
| Responsible Party: | University of MD ( Stephen Gottlieb ) |
| Study ID Numbers: | H-29283 |
| First Received: | April 1, 2008 |
| Last Updated: | April 7, 2008 |
| ClinicalTrials.gov Identifier: | NCT00654264 |
| Health Authority: | United States: Institutional Review Board |
|
|
|